Antivirals Targeting the Surface Glycoproteins of Influenza Virus: Mechanisms of Action and Resistance
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antivirals Targeting the Surface Glycoproteins of Influenza Virus: Mechanisms of Action and Resistance
Authors
Keywords
-
Journal
Viruses-Basel
Volume 13, Issue 4, Pages 624
Publisher
MDPI AG
Online
2021-04-06
DOI
10.3390/v13040624
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2017–2018
- (2020) Emi Takashita et al. ANTIVIRAL RESEARCH
- Phage capsid nanoparticles with defined ligand arrangement block influenza virus entry
- (2020) Daniel Lauster et al. Nature Nanotechnology
- In vitro profiling of laninamivir-resistant substitutions in N3 to N9 avian influenza neuraminidase subtypes and their association with in vivo susceptibility
- (2020) Ju Hwan Jeong et al. JOURNAL OF VIROLOGY
- Five Novel Non-Sialic Acid-Like Scaffolds Inhibit In Vitro H1N1 and H5N2 Neuraminidase Activity of Influenza a Virus
- (2020) Luis Márquez-Domínguez et al. MOLECULES
- In Vitro Characterization of Multidrug-Resistant Influenza A(H1N1)pdm09 Viruses Carrying a Dual Neuraminidase Mutation Isolated from Immunocompromised Patients
- (2020) Emi Takashita et al. Pathogens
- In vitro and in vivo characterization of novel neuraminidase substitutions in influenza A(H1N1)pdm09 identified using Laninamivir-mediated in vitro selection
- (2019) Khristine Kaith S. Lloren et al. JOURNAL OF VIROLOGY
- Influenza Virus Neuraminidase Structure and Functions
- (2019) Julie L. McAuley et al. Frontiers in Microbiology
- A small-molecule fusion inhibitor of influenza virus is orally active in mice
- (2019) Maria J. P. van Dongen et al. SCIENCE
- Source of oseltamivir resistance due to single E119D and double E119D/H274Y mutations in pdm09H1N1 influenza neuraminidase
- (2019) Chonnikan Hanpaibool et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- Superior inhibition of influenza virus hemagglutinin-mediated fusion by indole-substituted spirothiazolidinones
- (2019) Gökçe Cihan-Üstündağ et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Influenza Hemagglutinin Structures and Antibody Recognition
- (2019) Nicholas C. Wu et al. Cold Spring Harbor Perspectives in Medicine
- Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016–2017
- (2018) Angie Lackenby et al. ANTIVIRAL RESEARCH
- An oligothiophene compound neutralized influenza A viruses by interfering with hemagglutinin
- (2018) Xintian Shen et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Oseltamivir-zanamivir combination therapy suppresses drug-resistant H1N1 influenza A viruses in the hollow fiber infection model (HFIM) system
- (2018) Camilly P. Pires de Mello et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Five years of monitoring for the emergence of oseltamivir resistance in patients with influenza A infections in the Influenza Resistance Information Study
- (2018) Bruno Lina et al. Influenza and Other Respiratory Viruses
- Oligothiophene compounds inhibit the membrane fusion between H5N1 avian influenza virus and the endosome of host cell
- (2017) Zhibo Zhu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Drug Susceptibility Evaluation of an Influenza A(H7N9) Virus by Analyzing Recombinant Neuraminidase Proteins
- (2017) Larisa V Gubareva et al. JOURNAL OF INFECTIOUS DISEASES
- Phenotypic and genotypic analysis of influenza viruses isolated from adult subjects during a phase II study of intravenous zanamivir in hospitalised subjects
- (2016) Phillip J. Yates et al. ANTIVIRAL RESEARCH
- Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014–2015
- (2016) Aeron C. Hurt et al. ANTIVIRAL RESEARCH
- Structure-activity relationships of 3-O-β-chacotriosyl oleanane-type triterpenoids as potential H5N1 entry inhibitors
- (2016) Gaopeng Song et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Influenza A(H1N1)pdm09 virus exhibiting enhanced cross-resistance to oseltamivir and peramivir due to a dual H275Y/G147R substitution, Japan, March 2016
- (2016) Emi Takashita et al. Eurosurveillance
- Virus susceptibility and clinical effectiveness of anti-influenza drugs during the 2010–2011 influenza season in Russia
- (2016) I.A. Leneva et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Impact on antiviral resistance of E119V, I222L and R292K substitutions in influenza A viruses bearing a group 2 neuraminidase (N2, N3, N6, N7 and N9)
- (2016) Alexandre Gaymard et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Molecular Basis for Differential Patterns of Drug Resistance in Influenza N1 and N2 Neuraminidase
- (2016) Kristina L. Prachanronarong et al. Journal of Chemical Theory and Computation
- Post-marketing safety evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir: A drug-use investigation in patients with high risk factors
- (2016) Takuji Komeda et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol
- (2016) Rameshwar U. Kadam et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Peramivir: A Novel Intravenous Neuraminidase Inhibitor for Treatment of Acute Influenza Infections
- (2016) Malak M. Alame et al. Frontiers in Microbiology
- Characterization of a Large Cluster of Influenza A(H1N1)pdm09 Viruses Cross-Resistant to Oseltamivir and Peramivir during the 2013-2014 Influenza Season in Japan
- (2015) Emi Takashita et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013–2014
- (2015) Emi Takashita et al. ANTIVIRAL RESEARCH
- Molecular Docking of Potential Inhibitors for Influenza H7N9
- (2015) Zekun Liu et al. Computational and Mathematical Methods in Medicine
- Zanamivir-resistant influenza viruses with Q136K or Q136R neuraminidase residue mutations can arise during MDCK cell culture creating challenges for antiviral susceptibility monitoring
- (2015) Karen Little et al. Eurosurveillance
- E119D Neuraminidase Mutation Conferring Pan-Resistance to Neuraminidase Inhibitors in an A(H1N1)pdm09 Isolate From a Stem-Cell Transplant Recipient
- (2015) Arnaud G. L'Huillier et al. JOURNAL OF INFECTIOUS DISEASES
- Emergence of Multidrug-Resistant Influenza A(H1N1)pdm09 Virus Variants in an Immunocompromised Child Treated With Oseltamivir and Zanamivir
- (2015) Daisuke Tamura et al. JOURNAL OF INFECTIOUS DISEASES
- Clinical Implications of Antiviral Resistance in Influenza
- (2015) Timothy Li et al. Viruses-Basel
- Quercetin as an Antiviral Agent Inhibits Influenza A Virus (IAV) Entry
- (2015) Wenjiao Wu et al. Viruses-Basel
- Fitness Costs for Influenza B Viruses Carrying Neuraminidase Inhibitor-Resistant Substitutions: Underscoring the Importance of E119A and H274Y
- (2014) A. J. Burnham et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multiple Influenza A (H3N2) Mutations Conferring Resistance to Neuraminidase Inhibitors in a Bone Marrow Transplant Recipient
- (2014) Alireza Eshaghi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012–2013
- (2014) Adam Meijer et al. ANTIVIRAL RESEARCH
- Peptide entry inhibitors of enveloped viruses: The importance of interfacial hydrophobicity
- (2014) Hussain Badani et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Profiling and Characterization of Influenza Virus N1 Strains Potentially Resistant to Multiple Neuraminidase Inhibitors
- (2014) Yun Hee Baek et al. JOURNAL OF VIROLOGY
- Entry Properties and Entry Inhibitors of a Human H7N9 Influenza Virus
- (2014) Youhui Si et al. PLoS One
- Correction: Efficacy of Oseltamivir-Zanamivir Combination Compared to Each Monotherapy for Seasonal Influenza: A Randomized Placebo-Controlled Trial
- (2014) Xavier Duval et al. PLOS MEDICINE
- Estimating the Fitness Advantage Conferred by Permissive Neuraminidase Mutations in Recent Oseltamivir-Resistant A(H1N1)pdm09 Influenza Viruses
- (2014) Jeff Butler et al. PLoS Pathogens
- Aptamers that bind to the hemagglutinin of the recent pandemic influenza virus H1N1 and efficiently inhibit agglutination
- (2013) Subash C.B. Gopinath et al. Acta Biomaterialia
- Influenza virus resistance to neuraminidase inhibitors
- (2013) Mélanie Samson et al. ANTIVIRAL RESEARCH
- Favipiravir (T-705), a novel viral RNA polymerase inhibitor
- (2013) Yousuke Furuta et al. ANTIVIRAL RESEARCH
- Adjuvant Treatment With a Mammalian Target of Rapamycin Inhibitor, Sirolimus, and Steroids Improves Outcomes in Patients With Severe H1N1 Pneumonia and Acute Respiratory Failure*
- (2013) Chun-Hua Wang et al. CRITICAL CARE MEDICINE
- Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season
- (2013) Margaret Okomo-Adhiambo et al. Influenza and Other Respiratory Viruses
- Peramivir and laninamivir susceptibility of circulating influenza A and B viruses
- (2013) Sook-Kwan Leang et al. Influenza and Other Respiratory Viruses
- Parallel Screening of Wild-Type and Drug-Resistant Targets for Anti-Resistance Neuraminidase Inhibitors
- (2013) Kai-Cheng Hsu et al. PLoS One
- Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States
- (2012) Ha T. Nguyen et al. ANTIVIRAL RESEARCH
- Neuraminidase inhibitor susceptibility testing of influenza type B viruses in China during 2010 and 2011 identifies viruses with reduced susceptibility to oseltamivir and zanamivir
- (2012) Dayan Wang et al. ANTIVIRAL RESEARCH
- Combination therapy with amantadine, oseltamivir, and ribavirin for influenza A infection: safety and pharmacokinetics
- (2012) Sachiko Seo et al. ANTIVIRAL THERAPY
- A single E105K mutation far from the active site of influenza B virus neuraminidase contributes to reduced susceptibility to multiple neuraminidase-inhibitor drugs
- (2012) Seiichiro Fujisaki et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance
- (2012) Jennifer L. McKimm-Breschkin Influenza and Other Respiratory Viruses
- I223R Mutation in Influenza A(H1N1)pdm09 Neuraminidase Confers Reduced Susceptibility to Oseltamivir and Zanamivir and Enhanced Resistance with H275Y
- (2012) Jérome LeGoff et al. PLoS One
- Molecular basis of the structure and function of H1 hemagglutinin of influenza virus
- (2012) Nongluk SRIWILAIJAROEN et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Triple-Combination Antiviral Drug for Pandemic H1N1 Influenza Virus Infection in Critically Ill Patients on Mechanical Ventilation
- (2011) Won-Young Kim et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Mutations at Residue I223 of the Neuraminidase Protein on the Resistance Profile, Replication Level, and Virulence of the 2009 Pandemic Influenza Virus
- (2011) Andrés Pizzorno et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mechanism and Action of Flufirvitide, a Peptide Inhibitor of Influenza Virus Infection
- (2011) Hussain Badani et al. BIOPHYSICAL JOURNAL
- Frequency of Drug-resistant Viruses and Virus Shedding in Pediatric Influenza Patients Treated With Neuraminidase Inhibitors
- (2011) Daisuke Tamura et al. CLINICAL INFECTIOUS DISEASES
- Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus Infection
- (2011) I. F. Hung et al. CLINICAL INFECTIOUS DISEASES
- Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza
- (2011) Hideyuki Ikematsu et al. Expert Review of Anti-Infective Therapy
- Antiviral activity of arbidol, a broad-spectrum drug for use against respiratory viruses, varies according to test conditions
- (2011) Megan J. Brooks et al. JOURNAL OF MEDICAL VIROLOGY
- Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives
- (2011) Aeron C Hurt et al. LANCET INFECTIOUS DISEASES
- Inhibition of Influenza A Virus (H1N1) Fusion by Benzenesulfonamide Derivatives Targeting Viral Hemagglutinin
- (2011) Lei Zhu et al. PLoS One
- Failure of combination oral oseltamivir and inhaled zanamivir antiviral treatment in ventilator- and ECMO-treated critically ill patients with pandemic influenza A (H1N1)v
- (2011) Eskild Petersen et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Networks link antigenic and receptor-binding sites of influenza hemagglutinin: Mechanistic insight into fitter strain propagation
- (2011) Venkataramanan Soundararajan et al. Scientific Reports
- Detection of E119V and E119I Mutations in Influenza A (H3N2) Viruses Isolated from an Immunocompromised Patient: Challenges in Diagnosis of Oseltamivir Resistance
- (2010) M. Okomo-Adhiambo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Recovery of a Multidrug‐Resistant Strain of Pandemic Influenza A 2009 (H1N1) Virus Carrying a Dual H275Y/I223R Mutation from a Child after Prolonged Treatment with Oseltamivir
- (2010) Ha T. Nguyen et al. CLINICAL INFECTIOUS DISEASES
- Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations
- (2010) B. E. Davies JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The I222V Neuraminidase Mutation Has a Compensatory Role in Replication of an Oseltamivir-Resistant Influenza Virus A/H3N2 E119V Mutant
- (2010) P. Simon et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Effect of the Neuraminidase Mutation H274Y Conferring Resistance to Oseltamivir on the Replicative Capacity and Virulence of Old and Recent Human Influenza A(H1N1) Viruses
- (2010) Mariana Baz et al. JOURNAL OF INFECTIOUS DISEASES
- Generation and Characterization of Recombinant Pandemic Influenza A(H1N1) Viruses Resistant to Neuraminidase Inhibitors
- (2010) Andrés Pizzorno et al. JOURNAL OF INFECTIOUS DISEASES
- Sialic Acid-Mimic Peptides As Hemagglutinin Inhibitors for Anti-Influenza Therapy
- (2010) Teruhiko Matsubara et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structural and Functional Basis of Resistance to Neuraminidase Inhibitors of Influenza B Viruses
- (2010) Aaron J. Oakley et al. JOURNAL OF MEDICINAL CHEMISTRY
- Emergence of a Multidrug-Resistant Pandemic Influenza A (H1N1) Virus
- (2010) Erhard van der Vries et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oseltamivir-resistant Influenza A and B Viruses Pre- and Postantiviral Therapy in Children and Young Adults With Cancer
- (2010) Silvana Carr et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Permissive Secondary Mutations Enable the Evolution of Influenza Oseltamivir Resistance
- (2010) J. D. Bloom et al. SCIENCE
- Detection of antiviral resistance and genetic lineage markers in influenza B virus neuraminidase using pyrosequencing
- (2009) Tiffany G. Sheu et al. ANTIVIRAL RESEARCH
- Infections With Oseltamivir-Resistant Influenza A(H1N1) Virus in the United States
- (2009) Nila J. Dharan JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prolonged Influenza Virus Infection during Lymphocytopenia and Frequent Detection of Drug‐Resistant Viruses
- (2009) Jairo Gooskens et al. JOURNAL OF INFECTIOUS DISEASES
- Zanamivir-Resistant Influenza Viruses with a Novel Neuraminidase Mutation
- (2009) A. C. Hurt et al. JOURNAL OF VIROLOGY
- Emergence of Oseltamivir-Resistant Pandemic H1N1 Virus during Prophylaxis
- (2009) Mariana Baz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Surveillance for Neuraminidase Inhibitor Resistance among Human Influenza A and B Viruses Circulating Worldwide from 2004 to 2008
- (2008) T. G. Sheu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Characteristics of arbidol-resistant mutants of influenza virus: Implications for the mechanism of anti-influenza action of arbidol
- (2008) Irina A. Leneva et al. ANTIVIRAL RESEARCH
- Arbidol: A Broad-Spectrum Antiviral Compound that Blocks Viral Fusion
- (2008) Y. Boriskin et al. CURRENT MEDICINAL CHEMISTRY
- Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors
- (2007) Vanessa Escuret et al. JOURNAL OF CLINICAL VIROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now